How do you navigate the ever-changing treatment management landscape in metastatic Castrate Resistant Prostate Cancer (mCRPC) care? In this video series, leading physicians share their perspectives on mCPRC patient management with a focus on AR-targeted therapy and the utility of biomarkers, such as AR-V7, in helping guide treatment decisions.
Listen to peers talk about their patient management process and what they look for when deciding on the best treatment option for these patients. Learn how cutting-edge technology is providing better and faster insights into a patient’s cancer biology for personalized treatment guidance.
Frequently Asked Questions regarding
Real world patient case study utilizing AR-V7 testingDownload
Optimizing Treatment Decisions in Metastatic Castration-Resistant Prostate CancerDownload
Real world case study utilizing AR-V7 testingDownload
Content & Sponsorship provided by: